Serological differentiation of West Nile virus- and Usutu virus-induced antibodies by envelope proteins with modified cross-reactive epitopes

被引:4
|
作者
Berneck, Beatrice Sarah [1 ]
Rockstroh, Alexandra [1 ]
Barzon, Luisa [2 ]
Sinigaglia, Alessandro [2 ]
Vocale, Caterina [3 ]
Landini, Maria Paola [4 ]
Rabenau, Holger F. [5 ]
Schmidt-Chanasit, Jonas [6 ]
Ulbert, Sebastian [1 ]
机构
[1] Fraunhofer Inst Cell Therapy & Immunol, Perlickstr 1, D-04103 Leipzig, Germany
[2] Univ Padua, Dept Mol Med, Padua, Italy
[3] IRCCS Policlin S Orsola, CRREM Unita Operat Microbiol, Bologna, Italy
[4] Univ Bologna, Reg Reference Ctr Microbiol Emergencies CRREM, Clin Microbiol Unit, Orsola Malpighi Univ Hosp, Bologna, Italy
[5] Univ Hosp Frankfurt, Inst Med Virol, Frankfurt, Germany
[6] Bernhard Nocht Inst Trop Med, Hamburg, Germany
关键词
envelope protein; fusion loop; mutations; Usutu virus; West Nile virus; UNITED-STATES; TRANSMISSION; FLAVIVIRUS; DIAGNOSIS; VACCINE; EUROPE; DONOR;
D O I
10.1111/tbed.14429
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
West Nile virus (WNV) and Usutu virus (USUV) are mosquito-borne viruses that belong to the Japanese encephalitis virus serocomplex within the genus Flavivirus. Due to climate change and the expansion of mosquito vectors, flaviviruses are becoming endemic in increasing numbers of countries. WNV infections are reported with symptoms ranging from mild fever to severe neuro-invasive disease. Until now, only a few USUV infections have been reported in humans, mostly with mild symptoms. The serological diagnosis and differentiation between flavivirus infections, in general, and between WNV and USUV, in particular, are challenging due to the high degree of cross-reacting antibodies, especially of those directed against the conserved fusion loop (FL) domain of the envelope (E) protein. We have previously shown that E proteins containing four amino-acid mutations in and near the FL strongly reduce the binding of cross-reactive antibodies leading to diagnostic technologies with improved specificities. Here, we expanded the technology to USUV and analyzed the differentiation of USUV- and WNV-induced antibodies in humans. IgG ELISAs modified by an additional competition step with the heterologous antigen resulted in overall specificities of 93.94% for WNV Equad and 92.75% for USUV Equad. IgM antibodies against WNV could be differentiated from USUV IgM in a direct comparison using both antigens. The data indicate the potential of the system to diagnose antigenically closely related flavivirus infections.
引用
收藏
页码:2779 / 2787
页数:9
相关论文
共 49 条
  • [31] Large Scale Genome Analysis Shows that the Epitopes for Broadly Cross-Reactive Antibodies Are Predominant in the Pandemic 2009 Influenza Virus A H1N1 Strain
    Lara-Ramirez, Edgar E.
    Segura-Cabrera, Aldo
    Isabel Salazar, Ma
    Rodriguez-Perez, Mario A.
    Guo, Xianwu
    VIRUSES-BASEL, 2013, 5 (11): : 2796 - 2802
  • [32] HIGH-FREQUENCY OF CROSS-REACTIVE CYTOTOXIC LYMPHOCYTES-T ELICITED DURING THE VIRUS-INDUCED POLYCLONAL CYTOTOXIC LYMPHOCYTE-T RESPONSE
    NAHILL, SR
    WELSH, RM
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02): : 317 - 327
  • [33] Cross-reactive and major virus-specific epitopes are located at the N-terminal halves of the cylindrical inclusion proteins of turnip mosaic and zucchini yellow mosaic potyviruses
    A. K. Kundu
    K. Ohshima
    N. Sako
    H. Yaegashi
    Archives of Virology, 2000, 145 : 1437 - 1447
  • [34] Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination
    Manning, Nicola Mary
    Bachanek-Bankowska, Katarzyna
    Mertens, Peter Paul Clement
    Castillo-Olivares, Javier
    VACCINE, 2017, 35 (44) : 6024 - 6029
  • [35] Glycosylation of immunodominant linear epitopes in the carboxy-terminal region of the caprine arthritis-encephalitis virus surface envelope enhances vaccine-induced type-specific and cross-reactive neutralizing antibody responses
    Trujillo, JD
    Kumpula-McWhirter, NM
    Hötzel, KJ
    Gonzalez, M
    Cheevers, WP
    JOURNAL OF VIROLOGY, 2004, 78 (17) : 9190 - 9202
  • [36] Designed recombinant adenovirus type 5 vector induced envelope-specific CD8+ cytotoxic T lymphocytes and cross-reactive neutralizing antibodies against human immunodeficiency virus type 1
    Ura, Takehiro
    Yoshida, Atsushi
    Xin, Ke-Qin
    Yoshizaki, Shinji
    Yashima, Sayaka
    Abe, Shinya
    Mizuguchi, Hiroyuki
    Okuda, Kenji
    JOURNAL OF GENE MEDICINE, 2009, 11 (02): : 139 - 149
  • [37] Infection-permissive immunity against influenza virus provided by vaccination prevents loss of alveolar macrophages and modulates virus-induced cross-reactive cellular immune responses during subsequent influenza infections.
    Schotsaert, Michael
    Choi, Angela
    Spitaels, Jan
    Mina, Andrea Joselin Morales
    Garcia-Sastre, Adolfo
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [38] Cross-reactive and major virus-specific epitopes are located at the N-terminal halves of the cylindrical inclusion proteins of turnip mosaic and zucchini yellow mosaic potyviruses - Brief report
    Kundu, AK
    Ohshima, K
    Sako, N
    Yaegashi, H
    ARCHIVES OF VIROLOGY, 2000, 145 (07) : 1437 - 1447
  • [39] Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles
    Xu, Yufei
    Wang, Oingyong
    Han, Yehua
    Song, Guoxing
    Xu, Xuemei
    JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (07) : 907 - 913